How AI Search Is Recommending Revenue Cycle Management: Monthly Trends

Executive Summary

The Revenue Cycle Management (RCM) category's leadership position held in October 2026, but the gap beneath it has narrowed to its tightest point in the four-month series. athenahealth remains the coverage leader at 45.5% valid recommendation coverage, with an 8.6-point advantage over second-place R1 RCM (36.9%), the narrowest gap recorded in the series so far. The more consequential shift sits underneath that lead: R1 RCM, Waystar, and Optum have all built significant gains since July, compressing the upper tier from a single dominant brand into a four-way contest for recommendation credit.

The strongest upward mover this month was Optum, which entered tracking in September at 24.3% and rose to 31.4% in October, a significant gain that puts it 5.5 points behind R1 RCM. Optum also posted the largest single-month rise in the category, up 7.1 points from September to October, and now records 116 of 369 valid recommendations. R1 RCM (up 6.5 points month over month) and athenahealth (up 6.8 points) also moved upward, though R1 RCM's month-over-month gain did not clear the benchmark's significance threshold.

No continuously tracked brand posted a significant decline this month. The sharpest movement downward belongs to Optum Workers' Comp And Auto No-fault, a narrower tracking entity that recorded 5.2% coverage in July and August, entered the September series at 0.0%, and remains at 0.0% in October, a significant 5.2-point decline against the July baseline. Its collapse coincides with the arrival of the broader Optum entity, and the benchmark's notable-gap analysis shows the two series separating by 31.4 points, widening every month since September. This is best read as a category observation about how the Optum brand family is now measured rather than a verdict on either entity.

Against the full July-to-October series, five brands recorded significant gains (AGS Health, GeBBS Healthcare, Optum, R1 RCM, and Waystar), one recorded a significant decline (Optum Workers' Comp And Auto No-fault), and five held stable (athenahealth, Conifer Health Solutions, Ensemble Health Partners, Experian Health, and TruBridge). The benchmark's category summary describes the month as mixed: athenahealth's lead is stable, but the movement underneath it is not.

Each monthly run begins with 779 prompt-surface observations (425 unique questions) in July and 800 (583 unique questions) in October across the benchmark's defined AI/search surface universe. Of those, 779 in July and 800 in October mentioned a tracked brand or competitor; 608 in July and 517 in October were relevant, while 171 in July and 283 in October were irrelevant. The public metrics use the 498 qualified observations in July and the 369 qualified observations in October that survive both qualification stages. The benchmark tests six canonical AI surface families: ChatGPT, Copilot, Gemini, Perplexity, AI Overviews, and AI Mode.

Key Findings

AI Response Inconsistency Alerts

Questions This Section Answers

• Where did AI platforms give conflicting answers about RCM vendors?
• Which ownership and pricing claims about RCM companies could not both be correct?

The benchmark's conflict monitoring detected four critical or high-severity factual inconsistencies across five AI platforms: ChatGPT, Copilot, Gemini, AI Overviews, AI Mode, and Perplexity. These conflicts surface when different AI systems give incompatible answers to the same buyer-intent question, and they matter commercially because a prospect researching RCM vendors can encounter contradictory claims about the same company within a single buying cycle.

Ensemble Health Partners

AI platforms provided conflicting information about who controls Ensemble Health Partners. When asked who owns the company, Copilot stated that Thoreau, described as Apollo-backed, is the controlling shareholder after taking a majority stake in 2026, citing coverage from Outsource Accelerator, ICLG, and a PE forum report on the investment. Perplexity, answering the same question, stated that Warburg Pincus and Berkshire Partners are the primary owners and controllers, citing the company's SEC Form S-1 filing, Warburg Pincus's own investment page, and an Ensemble Health Partners blog post announcing the partnership. The two claims cannot both be correct, since the company cannot simultaneously be controlled by Thoreau and by Warburg Pincus and Berkshire Partners. This is a critical-severity conflict with 0.95 confidence. Flagged sources on the Thoreau side described the group as being in advanced talks to acquire Ensemble and become the controlling stakeholder, while sources on the Warburg Pincus and Berkshire Partners side described the company as owned primarily by those firms.

athenahealth

Two high-severity conflicts were detected for athenahealth. In the first, AI systems disagreed on the company's corporate structure. When asked to name the major RCM companies in healthcare, Perplexity stated that athenahealth is now part of Veradigm, citing RCM company roundups from Keragon, Helpware, and CareCloud. ChatGPT, answering the same question, listed athenahealth as a separate standalone RCM technology and platform company and listed Veradigm separately as its own company, citing an Everest Group PEAK Matrix assessment, a Mordor Intelligence companies list, and R1 RCM's own about page. A company cannot simultaneously be a subsidiary of Veradigm and an independent entity distinct from it. This conflict carried 0.9 confidence.

In the second, AI systems disagreed on athenahealth's implementation and setup cost range. When asked how much Athena EMR costs per month, AI Overviews stated that implementation and setup runs from $2,000 to $5,000 per provider, rising to as much as $40,000 for full enterprise deployment, citing EHR Source, a FindEMR pricing guide, and athenahealth's own cost and value page. AI Mode, answering the same question, stated that implementation and setup generally ranges from $15,000 to $40,000, citing Software Finder and a redirected Transcure page. Those two minimum-cost claims are incompatible. This pricing conflict carried 0.85 confidence, and the flagged source on the AI Mode side described implementation and setup at $15,000 to $40,000 for system deployment, workflow configuration, and practice-specific customization.

R1 RCM

AI platforms provided conflicting information about which company is the largest dedicated RCM provider. When asked who the largest revenue cycle management company is, ChatGPT stated that R1 RCM is generally considered the largest pure-play RCM services company, citing the R1 RCM Wikipedia entry, a Definitive Healthcare list of largest RCM vendors, and a Research and Markets companies article. Copilot, answering the same question, stated that Oracle Cerner is the largest dedicated RCM provider and characterized R1 RCM as only a major outsourcing provider with approximately $1.8 billion in RCM revenue, citing Market Growth Reports and Verified Market Research. Both answers cannot be true. This conflict carried 0.9 confidence and high severity.

Benchmark Context

Questions This Section Answers

• How does the qualified RCM benchmark set differ from the raw collection universe?
• How did the qualified observation count change from July to October?

The report separates the raw collection universe from the qualified analysis set. Brand-level recommendation percentages are calculated within the qualified benchmark set.

The intermediate months show the collection universe staying largely stable while the qualified set contracted. August collected 785 prompt-surface observations and qualified 462; September collected 800 and qualified 375. The October qualified total of 369 is the smallest in the series, and the share of relevant prompts fell from 608 of 779 in July to 517 of 800 in October.

Benchmark-Level Metrics

The intermediate months show a steady climb rather than a single jump. Recommendation-shaped answer share moved from 26.5% in July to 29.2% in August and 27.5% in September before reaching 48.0% in October. Valid recommendation shortlist share moved from 48.8% in July to 48.1% in August and 50.1% in September before reaching 65.0% in October. A materially larger share of a smaller qualified set is now carrying recommendation credit.

AI Recommendation Trend

Questions This Section Answers

• Who leads RCM recommendation coverage, and how has the gap beneath the leader changed?
• Which RCM vendors recorded significant gains or declines against the July baseline?

The category leader held its position while a four-way upper tier formed beneath it

athenahealth's lead over second place widened slightly in absolute terms this month, but the more significant pattern is that R1 RCM, Waystar, and Optum all now sit above 29% coverage, where only athenahealth cleared that threshold in July. The category has moved from a single dominant brand with a long tail to a leader plus a compressed challenger group.

Five brands exceeded normal month-to-month variation against the July baseline: AGS Health, GeBBS Healthcare, Optum, R1 RCM, and Waystar all recorded significant gains, while Optum Workers' Comp And Auto No-fault recorded a significant decline. The category-level change came from the combination of those movements rather than a single driver, and no continuously tracked brand fell significantly over the series.

What Changed This Month

Questions This Section Answers

• Which RCM vendor posted the largest single-month move, and what drove it?
• Why is athenahealth's presence declining while its recommendation coverage holds?
• Does the Optum tracking split reflect a competitive change or a measurement change?

Optum: The strongest mover in the category, on both the month and the series

Optum's valid recommendation coverage rose from 24.3% in September to 31.4% in October, a 7.1-point gain that cleared the benchmark's significance threshold and stands as the largest single-month move in the current series. Against the July baseline, the entity entered tracking only in September, so no July or August coverage figure exists for comparison; the 0.0% shown in the series reflects its absence from tracking rather than a measured decline.

The October result rests on 116 valid recommendations out of 369 qualified observations. Raw mention presence stands at 46.9%, with the company present in 173 observations, and rank-one recommendation share is 12.7%, representing 47 first-position placements. Top-three recommendation share is 23.8%.

Optum's profile is unusual in this category: its presence rate of 46.9% is lower than R1 RCM's 48.2% and only modestly above Waystar's 42.0%, yet its coverage of 31.4% sits above both. That pattern indicates a higher share of its appearances converting into recommendation credit rather than presence alone. The benchmark's notable-gap analysis also shows Optum pulling away from TruBridge by 28.7 points, a separation that has widened every month since the entity entered tracking.

Highest-priority diagnostic: Which prompt contexts and surfaces convert Optum's presence into recommendation credit at a higher rate than its peers, and how does that pattern differ from the narrower workers' comp entity it replaced?

R1 RCM: A significant series gain that has now moderated month over month

R1 RCM's valid recommendation coverage rose from 22.5% in July to 36.9% in October, a significant 14.4-point gain across the series, with 136 of 369 valid recommendations in October. The month-over-month reading is quieter: coverage moved up 6.5 points from September, which did not clear the benchmark's significance threshold for a single-month move.

The series gain was driven by simultaneous improvement in presence and placement. Raw mention presence rose from 33.3% in July to 48.2% in October, with the company present in 178 observations. Top-three recommendation share rose from 16.9% to 29.3%, and rank-one share rose from 6.8% to 16.8%, representing 62 first-position placements in October, the highest rank-one count in the category behind athenahealth.

The distinction worth noting is that R1 RCM's rank-one rate now exceeds athenahealth's 8.9% even though its overall coverage trails by 8.6 points. R1 RCM is winning the top slot in a narrower band of prompts while athenahealth is recommended across a much wider set.

Highest-priority diagnostic: Which prompt topics drive R1 RCM's high rank-one rate, and whether those topics overlap with the contexts where athenahealth's coverage advantage is concentrated?

Waystar: Three consecutive months of upward coverage, with placement gains to match

Waystar's valid recommendation coverage rose from 15.1% in July to 29.5% in October, a significant 14.4-point gain, with 109 of 369 valid recommendations. The company's coverage has risen in each of the three months since the baseline, the longest unbroken upward streak in the category alongside GeBBS Healthcare, though the 5.0-point September-to-October move did not clear the significance threshold.

Presence and placement moved together. Raw mention presence climbed from 24.3% in July to 42.0% in October, reaching 155 observations. Top-three share rose from 8.2% to 19.5%, and rank-one share rose from 3.6% to 8.1%, representing 30 first-position placements.

Waystar's pattern is the clearest example in the category of a brand whose presence, top-three placement, and first-position credit all advanced together, a combination consistent with broader recommendation gains rather than visibility alone. Its rank-one rate of 8.1% sits close to athenahealth's 8.9% despite a 16-point coverage gap.

Highest-priority diagnostic: Which surfaces and prompt topics account for Waystar's three-month streak, and whether the placement gains are concentrated in the same contexts as its presence gains?

athenahealth: The lead is stable, but presence and coverage now point in opposite directions

athenahealth remains the category leader at 45.5% valid recommendation coverage in October, up 3.7 points from 41.8% in July and up 6.8 points from September, with 168 of 369 valid recommendations. Neither the series nor the month-over-month coverage move cleared the benchmark's significance threshold; the benchmark classifies the brand as stable.

The presence signal runs the other way. Raw mention presence fell from 89.2% in July to 75.6% in October, a 13.6-point decline, with the company present in 279 observations. Rank-one recommendation share eased from 10.4% to 8.9%, while top-three share rose from 26.9% to 31.2%.

The divergence is the story: athenahealth is appearing in a materially narrower set of answers while being recommended in a larger share of the answers where it does appear. Its 45.5% coverage against 75.6% presence implies an unusually high conversion rate from appearance to recommendation, which is a different competitive posture than the presence-led gains posted by R1 RCM and Waystar.

Highest-priority diagnostic: Which surfaces and prompt patterns account for the sustained presence decline, and whether the prompts athenahealth no longer appears in are the same contexts where the challenger group is gaining?

GeBBS Healthcare and AGS Health: Mid-tier risers with three-month streaks

GeBBS Healthcare's coverage rose from 8.0% in July to 17.3% in October, a significant 9.3-point gain, with 64 of 369 valid recommendations, moving the company to 5th place. Raw mention presence rose from 9.4% to 19.0%, reaching 70 observations, and top-three share rose from 3.2% to 5.4%. Rank-one share eased from 1.2% to 0.3%, representing a single first-position placement in October. Coverage has risen in each of the three months since the baseline.

AGS Health's coverage rose from 4.8% in July to 12.2% in October, a significant 7.4-point gain, with 45 of 369 valid recommendations, holding 6th place. Raw mention presence climbed from 6.4% to 15.4%, reaching 57 observations. Top-three share rose from 1.4% to 3.8%, and rank-one share rose from 0.0% to 1.1%, representing 4 first-position placements. Coverage has also risen in each of the three months since the baseline.

Both brands built their gains primarily through wider presence, and both show rank-one rates at or near the bottom of the actively tracked set. For AGS Health, 4 rank-one placements and 14 top-three placements out of 369 qualified observations are small absolute counts, and small-count caution applies when reading the movement. The same caution applies to GeBBS Healthcare's single rank-one placement.

Highest-priority diagnostic: For each brand, whether the expanded presence is converting into recommendation credit at a rate comparable to the category's placement leaders, or whether the gains remain concentrated in secondary and tertiary mentions.

The Optum tracking split: A measurement change, not a competitive verdict

The narrowing Optum Workers' Comp And Auto No-fault entity held 5.2% coverage in both July and August, recorded no qualifying observations in September, and remains at 0.0% in October, a significant 5.2-point decline against the July baseline. Its presence-based supporting metrics show 8.0% raw mention presence, 3.0% top-three share, and 1.0% rank-one share at the July baseline, with no current-month equivalent because the entity records no qualifying observations.

The broader Optum entity entered tracking in September at 24.3% and rose to 31.4% in October. The benchmark's notable-gap analysis shows the two series separating by 31.4 points as of October, a gap that has widened every month since September. A separate notable gap places Optum 28.7 points ahead of TruBridge, also widening every month.

This is best read as a category observation about how the Optum brand family is now being measured rather than a statement about either entity's competitive standing. The coexistence of a broad Optum entity at 31.4% coverage and a narrower workers' comp entity at 0.0% reflects a change in tracking scope that coincided with the broader entity's arrival.

Highest-priority diagnostic: Whether the prompts that previously surfaced the narrower workers' comp entity are now resolving to the broader Optum entity, or whether those prompt contexts have dropped out of the qualified set entirely.

TruBridge: Presence up, coverage down, sentiment at the low end of the category

TruBridge's valid recommendation coverage moved from 3.8% in July to 2.7% in October, a 1.1-point decline that stayed within the benchmark's normal range, with 10 of 369 valid recommendations. The month-over-month direction reversed: coverage rose 1.6 points from September's 1.1%. Neither move cleared the significance threshold.

Raw mention presence rose from 6.6% in July to 11.9% in October, reaching 44 observations, a 5.3-point gain. Top-three share eased from 2.0% to 1.4%, representing 5 placements, and rank-one share fell from 0.4% to 0.0%, with no first-position placements in October. Net sentiment score stands at 0.3, the lowest in the tracked set and down from 0.7 at the baseline.

TruBridge is appearing in more AI answers than it did in July while converting a smaller share of those appearances into recommendation credit, and the sentiment attached to its mentions has fallen sharply. With 10 valid recommendations and 5 top-three placements out of 369 qualified observations, small-count caution is essential when interpreting any of these movements.

Highest-priority diagnostic: In what non-recommendation contexts TruBridge's expanded presence is occurring, and which competitors are capturing the recommendation credit in prompts where TruBridge appears without being recommended.

Buyer-Intent Interpretation

Questions This Section Answers

• Which buyer-intent clusters did the qualified RCM observations fall into?
• What can the benchmark not yet explain about how AI systems compare RCM vendors?

Every qualified observation in July, August, September, and October fell into the brand recommendation cluster, with 498 observations in July, 462 in August, 375 in September, and 369 in October assigned there. No observations were recorded in the pricing and value cluster or the multi-brand comparison cluster in any month of the series.

This concentration means the public benchmark can establish which vendors AI systems recommend for RCM, how often, and at what rank, but it cannot yet answer how AI systems characterize pricing differences between vendors, how they compare value propositions, or where each brand lands in a direct head-to-head framing. The commercial weight of recommendation coverage is clear from the data. The reasoning underneath those recommendations, including the attributes and cost claims AI systems attach to each option, remains outside what the current public benchmark set can measure.

Brand Opportunity Summary

Questions This Section Answers

• Which RCM brand has the highest-priority diagnostic in October, and what does it show?
• Where does each RCM vendor's coverage signal point for further investigation?

The benchmark identifies where attention is warranted across the RCM category; a company-level analysis is needed to explain why these patterns are emerging for any individual brand.

Evidence Behind the Benchmark

The aggregate metrics are built from prompt-level observations capturing the query, the AI surface, the recommendation outcome, the rank position, sentiment, and citations where exposed. Company-level analysis can go deeper into prompt phrasing, competitor presence, surface-level differences, and the evidence sources that shape each AI answer. Source presence in an AI output is not automatically treated as proof of causation.

About This Benchmark

This report is part of the LLM Authority Index AI Visibility Market Discovery research program.

• AI Visibility Industry Market Index
• AI Visibility Industry Market Methodology
• AI Visibility Industry Market Metrics
• AI Visibility Industry Market Standards

Report-Specific Interpretation Notes

• The qualified benchmark denominator (369 observations in October) differs from the raw collection size (800 prompts), and brand-level percentages reflect only qualified observations.
• Small-count movements warrant caution: TruBridge's 10 valid recommendations and AGS Health's 4 rank-one placements mean a change of a few observations can move those percentages meaningfully.
• The Optum Workers' Comp And Auto No-fault series reflects a change in how the Optum brand family is tracked rather than a purely organic coverage movement, and should be read as a measurement change rather than a competitive verdict.
• Movement between months identifies changes worth investigating; it does not by itself establish the cause of those changes.

Next Step

The Public Benchmark Shows Where a Brand Is Winning or Losing. A Company-Level Audit Shows Why.

The aggregate percentages in this report raise questions the public benchmark cannot answer. Which high-intent prompts is each vendor winning outright, and which is it losing? When a brand loses the recommendation, which competitor takes it? What attributes, capabilities, and cost claims do AI systems associate with each RCM option, and how much do those associations diverge across surfaces? Which external sources, reviews, filings, and publications are shaping the answers, and which of those sources are carrying conflicting claims into the same buying cycle? These are the questions beneath the numbers, and they determine whether a coverage figure represents durable authority or a fragile mention.

A company-specific AI visibility audit maps those prompt, surface, competitor, ranking, sentiment, and evidence-source patterns into a prioritized visibility strategy. It identifies where a brand is genuinely recommended versus merely visible, which competitor is capturing the credit it loses, and what evidence gaps are holding back stronger recommendation placement.

Request an AI visibility audit